Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05801341 · ClinicalTrials.gov registry record · NA
Inpatient COVID-19 Lollipop Study
A NA study, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT05801341 is a NA study that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 17 participants.
The verdict
NCT05801341, a NA study, was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
This study is being done to see if collecting saliva samples with a "lollipop" collection method works as well as nasopharyngeal samples for COVID-19 polymerase chain reaction (PCR) testing. 225 COVID-positive participants aged 4 years and above admitted to a hospital in the Madison, Wisconsin metropolitan area will be enrolled over a 6 month period.
Interventions
- DEVICE Lollipop
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2023-04-20 |
| Est. Completion | 2023-05-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05801341
The ClinicalTrials.gov registry entry for NCT05801341 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lollipop is the first listed.
NCT05801341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05801341 about?
NCT05801341 is a clinical study titled "Inpatient COVID-19 Lollipop Study". This study is being done to see if collecting saliva samples with a "lollipop" collection method works as well as nasopharyngeal samples for COVID-19 polymerase chain reaction (PCR) testing. 225 COVID-positive participants aged 4 years and above admitted to a hospital in the Madison, Wisconsin metro...
What is the current status of trial NCT05801341?
This trial is currently terminated. It is a NA study. The enrollment target is 17 participants. The study started on 2023-04-20. Estimated completion is 2023-05-24.
What interventions are being tested in trial NCT05801341?
The interventions under investigation include: Lollipop (DEVICE).
Who is sponsoring clinical trial NCT05801341?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.